Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR

NCT03410654 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03410654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03410654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Completed
Start date
October 24, 2018
Completion date
July 1, 2024
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant; complications